EV Biologics Inc (YECO)
0.6221
+0.02
(+3.32%)
USD |
OTCM |
May 09, 16:00
EV Biologics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 43.65% |
| December 31, 2016 | 38.64% |
| September 30, 2016 | 32.50% |
| June 30, 2016 | 35.16% |
| March 31, 2016 | 38.47% |
| December 31, 2015 | 38.04% |
| September 30, 2015 | 40.79% |
| June 30, 2015 | 36.77% |
| Date | Value |
|---|---|
| March 31, 2015 | 37.89% |
| December 31, 2014 | 36.00% |
| September 30, 2014 | 35.40% |
| June 30, 2014 | 37.66% |
| March 31, 2014 | 39.67% |
| December 31, 2013 | 36.83% |
| September 30, 2013 | 38.52% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |